𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Could carboplatin be inferior to cisplatin in management of small-cell lung cancer?

✍ Scribed by Jezdić, S; Jelić, S; Nikolić-Tomašević, Z; Popov, I; Radosavljević, D

Book ID
118569671
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
139 KB
Volume
29
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Picoplatin overcomes resistance to cell
Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin
✍ Chi-Hui Tang; Christi Parham; Ellyn Shocron; Gerald McMahon; Neela Patel 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 382 KB

## Purpose Picoplatin is a new generation platinum designed to overcome platinum resistance. The goal of this study was to assess picoplatin anti-tumor activity and measure various cellular parameters in small-cell lung cancer (SCLC) cells resistant to cell killing by cisplatin and carboplatin. ##